(800) 369-0899
(215) 569-4000
Contact Us Today
One of the world’s leading mesothelioma research centers, the University of Hawaii, in collaboration with researchers from Fox Chase Cancer Center in Philadelphia, Pennsylvania, has released a study that concludes that certain skin lesions may be indicators of an increased risk for mesothelioma. The study determined that the mole-like tumors typically occur in individuals with a BAP1 gene mutation. Previously, the gene mutation was linked to a higher likelihood of several other types of cancers. Now, the team’s research has provided evidence that the mutated BAP1 gene is commonly present in mesothelioma patients. Linking the particular skin moles to the mutated BAP1 gene and now linking the gene mutation to occurrences of mesothelioma can lead to earlier detection and more effective treatment of mesothelioma.
The presence of the particular skin moles and identification of the mutated BAP1gene in individuals can help doctors determine who is at risk before mesothelioma develops. Therefore, testing for the deadly disease may occur even before symptoms are evident. As with many cancers, early detection gives mesothelioma patients additional treatment options and may greatly increase the patient’s odds at survival. If you have a suspicious looking mole, you should always seek expert medical advice immediately.
If you have been diagnosed with mesothelioma or another asbestos-related disease or illness, contact the law firm of Brookman, Rosenberg, Brown & Sandler. Our Philadelphia mesothelioma attorneys have handled more than 10,000 asbestos cases throughout Pennsylvania and New Jersey. We understand how high the physical and emotional cost can be when it comes to asbestos-related diseases and we will assist you in recovering the compensation you and your family deserve. Call us at (215) 569-4000 or contact us online to schedule a free consultation today.